Abstract
Endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms has been challenged by a number of groups, and the shortcomings of this procedure have been documented in the scientific literature. However, patients and physicians continue to pursue this procedure as a viable means of treating abdominal aortic aneurysms. Both device evolution and advancement of technical skills have led to dramatic improvements in the outcomes of EVAR within the last decade. These improvements and accomplishments have also been chronicled in the literature. This review looks at the successes of EVAR, based on both US Food and Drug Administration trials and independent studies comparing conventional open repair and endovascular repair.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 307-313 |
| Number of pages | 7 |
| Journal | Seminars in Vascular Surgery |
| Volume | 17 |
| Issue number | 4 SPEC. ISS. |
| DOIs | |
| State | Published - Dec 2004 |
Fingerprint
ASJC Scopus subject areas
- Surgery
- Cardiology and Cardiovascular Medicine
Cite this
Overview of success of EVAR : Progress to date. / Longo, G. Matthew; Eskandari, Mark K.
In: Seminars in Vascular Surgery, Vol. 17, No. 4 SPEC. ISS., 12.2004, p. 307-313.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Overview of success of EVAR
T2 - Progress to date
AU - Longo, G. Matthew
AU - Eskandari, Mark K.
PY - 2004/12
Y1 - 2004/12
N2 - Endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms has been challenged by a number of groups, and the shortcomings of this procedure have been documented in the scientific literature. However, patients and physicians continue to pursue this procedure as a viable means of treating abdominal aortic aneurysms. Both device evolution and advancement of technical skills have led to dramatic improvements in the outcomes of EVAR within the last decade. These improvements and accomplishments have also been chronicled in the literature. This review looks at the successes of EVAR, based on both US Food and Drug Administration trials and independent studies comparing conventional open repair and endovascular repair.
AB - Endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms has been challenged by a number of groups, and the shortcomings of this procedure have been documented in the scientific literature. However, patients and physicians continue to pursue this procedure as a viable means of treating abdominal aortic aneurysms. Both device evolution and advancement of technical skills have led to dramatic improvements in the outcomes of EVAR within the last decade. These improvements and accomplishments have also been chronicled in the literature. This review looks at the successes of EVAR, based on both US Food and Drug Administration trials and independent studies comparing conventional open repair and endovascular repair.
UR - http://www.scopus.com/inward/record.url?scp=10944229239&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=10944229239&partnerID=8YFLogxK
U2 - 10.1053/j.semvascsurg.2004.09.007
DO - 10.1053/j.semvascsurg.2004.09.007
M3 - Article
C2 - 15614756
AN - SCOPUS:10944229239
VL - 17
SP - 307
EP - 313
JO - Seminars in Vascular Surgery
JF - Seminars in Vascular Surgery
SN - 0895-7967
IS - 4 SPEC. ISS.
ER -